Polysorbate 20 degradation in biotherapeutic formulations and its

Enzyme-induced hydrolysis of polysorbate 20 and formation of subvisible particles was evaluated using relevant analytical techniques to understand the impact of

Polysorbate degradation in biotherapeutic formulations: Identification and discussion of current root causes

Pharmaceutics, Free Full-Text

Polysorbate degradation in biotherapeutic formulations: Identification and discussion of current root causes

Nelli Erwin on LinkedIn: Poloxamer 188 as surfactant in biological formulations – An alternative…

Figure 4 from Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways.

Residual Host Cell Protein Promotes Polysorbate 20 Degradation in a Sulfatase Drug Product Leading to Free Fatty Acid Particles - Journal of Pharmaceutical Sciences

Full article: Prediction of long-term polysorbate degradation according to short-term degradation kinetics

View of ANALYSIS OF POLYSORBATE 80 SOLUTION STABILITY UNDER STRESS CONDITIONS TO ENSURE ITS QUALITY AS A BIOPHARMACEUTICAL EXCIPIENT

Enzymatic degradation pattern of polysorbate 20 impacts interfacial properties of monoclonal antibody formulations - ScienceDirect

Polysorbates 20 and 80 Used in the Formulation of Protein Biotherapeutics: Structure and Degradation Pathways - Journal of Pharmaceutical Sciences

Polysorbate, the Good, the Bad and the Ugly American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology

Formulation mitigations for particle formation induced by enzymatic hydrolysis of polysorbate 20 in protein-based drug products: insights from a full-factorial longitudinal study, AAPS Open

Full article: Prediction of long-term polysorbate degradation according to short-term degradation kinetics

Mechanistic understanding of metal-catalyzed oxidation of polysorbat